TOP TIERMARKET NEWSWIRE
News & sentiment

CULLINAN THERAPEUTIC (CGEM) — News & AI sentiment

CULLINAN THERAPEUTIC (CGEM) news roundup. 3 stories in the past week, 4 over 30 days. Average 30-day sentiment is 58.3/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 1 sales totalling $143K — net selling of $143K. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
3
avg sentiment 63.7/100
30d stories
4
avg sentiment 58.3/100
Insider net (90d)
$143K
0 buys · 1 sells
Congress (90d)
0
0 buys · 0 sells

Latest stories on CGEM

Cullinan Therapeutics stock rises on FDA meeting for CLN-049
Investing.com Markets63 · neutralgeneral
2d ago
Why is Cullinan Therapeutics stock climbing today?
Investing.com Markets55 · neutralgeneral
2d ago
2d ago
Jul 7
Jun 16
Cullinan Therapeutics: Heading Toward Paydirt
Seeking Alpha73 · bullishproduct/pr
Jun 11
Jun 10
Jun 10
Jun 10
Jun 10
Jun 10
Jun 8
Jun 8
Jun 6
Jun 1
May 26
Cullinan Metals names Christopher Huggins as CEO
Seeking Alpha50 · neutralgeneral
May 14
Open CGEM in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →